Fang X, Ming C, Cen Y, Lin H, Zhan K, Yang S, Li L, Cao G, Li Q and Ma X (Corresponding author). Post-sequelae one year after hospital discharge among older COVID-19 patients: a multi-center prospective cohort study. The Journal of infection. 2022. 84(2): 179-186.
Zhan K, Zhang X, Wang B, Jiang Z, Fang X, Yang S, Jia H, Li L, Cao G, Zhang K and Ma X (Corresponding author). Short and long-term prognosis of glycemic control in COVID-19 patients with type 2 diabetes. QJM. 2022. 115(3): 131-139.
Zhang Y, Wu S, Ma X (Corresponding author). Consciousness of evidence-based medicine in public health emergencies. Int J Surg. 2023;109(1):55-56.
Ma X (Corresponding author). High time for outlining the connotation and scope of war epidemiology. Int J Surg. 2022;106:106932.
Zhan K, Weng L, Qi L,….., Ma X (Corresponding author). Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis. Ann Pharmacother. 2022:10600280221133577.
Li L, Zhao N, Ma, X(Co-first author), Sun F, He B, Qin Z, Wu K, Wang X, Zhao Q, Zhang S, Nie N, Luo D, Sun B, et al. Personalised Variable vs Fixed Dose Systemic Corticosteroid Therapy in Hospitalized Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective, Multicentered, Randomised, Open-Label Clinical Trial. Chest. 2021.
Li, L.; Fang, X.; Cheng, L.; Wang, P.; Li, S.; Yu, H.; Zhang, Y.; Jiang, N.; Zeng, T.; Hou, C.; Zhou, J.; Li, S.; Pan, Y.; Li, Y.; Nie, L.; Li, Y.; Sun, Q.; Jia, H.; Li, M.; Cao, G.; Ma X (Corresponding author), Development and validation of a prognostic nomogram for predicting in-hospital mortality of COVID-19: a multicenter retrospective cohort study of 4086 cases in China. Aging 2021, 13 (3), 3176-3189.
Fang, X.; Li, S.; Yu, H.; Wang, P.; Zhang, Y.; Chen, Z.; Li, Y.; Cheng, L.; Li, W.; Jia, H.; Ma X (Corresponding author), Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging 2020, 12 (13), 12493-12503.
Li, S.; Xu, Y.; Zhang, Y.; Nie, L.; Ma, Z.; Ma, L.; Fang, X.; Ma X (Corresponding author), Mendelian randomization analyses of genetically predicted circulating levels of cytokines with risk of breast cancer. NPJ Precis Oncol 2020, 4, 25.
Luo, Y.; Wang, X.; Ma, L.; Ma, Z.; Li, S.; Fang, X.; Ma X (Corresponding author), Bioinformatics analyses and biological function of lncRNA ZFPM2-AS1 and ZFPM2 gene in hepatocellular carcinoma. Oncol Lett 2020, 19 (6), 3677-3686.
Montazeri, Z.; Li, X.; Nyiraneza, C.; Ma, X.; Timofeeva, M.; Svinti, V.; Meng, X.; He, Y.; Bo, Y.; Morgan, S.; Castellvi-Bel, S.; Ruiz-Ponte, C.; Fernandez-Rozadilla, C.; Carracedo, A.; Castells, A.; Bishop, T.; Buchanan, D.; Jenkins, M. A.; Keku, T. O.; Lindblom, A.; van Duijnhoven, F. J. B.; Wu, A.; Farrington, S. M.; Dunlop, M. G.; Campbell, H.; Theodoratou, E.; Zheng, W.; Little, J., Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer. Gut 2019.
Zhang, X.; Wang, F.; Shen, Y.; Zhang, X.; Cen, Y.; Wang, B.; Zhao, S.; Zhou, Y.; Hu, B.; Wang, M.; Liu, Y.; Miao, H.; Jones, P.; Ma, X.; He, Y.; Cao, G.; Cheng, L.; Li, L., Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China. JAMA Netw Open 2021, 4 (9), e2127403.
Ma X, Zhang B, Zheng W: Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Gut 2014, 63(2):326-36
Ma X, Xu B, Liu Q, Zhang Y, Xiong H, Li Y: Effectiveness of evidence-based medicine training for undergraduate students at a chinese military medical university: A self-controlled trial. BMC medical education 2014;14:133.
Xu B, Ma X (Corresponding author), Xiong H, Li Y. Complete genome sequence of 285P, a novel T7-like polyvalent E. coli bacteriophage. Virus genes. 2014;48(3):528-533.
Ma X, Song Z. Impact: China needs to review its metrics. Nature 2013; 503(7475):198
Ma X, Beeghly-Fadiel A, Shu XO, Li H, Yang G, Gao YT, Zheng W: Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women's Health Study. British Journal of Cancer 2013, 109(3):751-755.
Ma XY, Beeghly-Fadiel A, Lu W, et al. Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians. Cancer Epidemiol Biomarkers Prev. 2012; 21(7),1176-1184.
Ma XY, Alicia Beeghly-Fadiel, Qiuyin Cai, Wei Lu, Yu-Tang Gao, Jirong Long, Ben Zhang, Jiajun Shi, Ying Zheng, Xiao-Ou Shu, and Wei Zheng. Transforming growth factor beta signaling pathway variants and breast cancer risk: results from the Shanghai Breast Cancer Genetics Study. Cancer research. 2012; 72 (8 Supplement): 2604
Ma X, Cai Q, Delahanty R, Shu XO, Zhang B, Lu W, et al. No Association between Ovarian Cancer Susceptibility Variants and Breast Cancer Risk among Chinese Women. Cancer Epidemiol Biomarkers Prev. 2013, 22(3):467-9
Ma XY, Chen C, Xiong H, Li Y. Transforming growth factorbeta1 l10p variant plays an active role on the breast cancer susceptibility in caucasian: Evidence from 10,392 cases and 11,697 controls. Breast Cancer Res Treat. 2010;124:453-457
Ma XY, Qi X, Chen C, Lin H, Xiong H, Li Y, Jiang J. Association between cyp19 polymorphisms and breast cancer risk: Results from 10,592 cases and 11,720 controls. Breast Cancer Res Treat. 2010;122 (2):495-501
Ma XY, Chen C, Xiong H, Fan J, Li Y, Lin H, Xu R, Huang G, Xu B. No association between sod2 val16ala polymorphism and breast cancer susceptibility: A meta-analysis based on 9,710 cases and 11,041 controls. Breast Cancer Res Treat. 2010;122(2):509-514
Ma XY, Liu J, Song Z (2011) Associations of the ATP-binding cassette transporter A1 R219K polymorphism with HDL-C level and coronary artery disease risk: a meta-analysis. Atherosclerosis. 2011; 215(2): 428-434
Ma XY, Liu JP, Song ZY. Glycemic load, glycemic index and risk of cardiovascular diseases: meta-analyses of prospective studies. Atherosclerosis 2012;223(2):491-6
Qi X, Ma XY(co-first author), Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: A meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat. 2010;123(2):499-506
Chen C, Ma XY(co-first author), Zhong M, Yu Z. Extremely low-frequency electromagnetic fields exposure and female breast cancer risk: A meta-analysis based on 24,338 cases and 60,628 controls. Breast Cancer Res Treat. 2010;123(2):569-576
